Treatment of a Whole Population Sample of Alzheimer’s Disease with Donepezil over a 4-Year Period: Lessons Learned

Publisher： Karger

E-ISSN： 1421-9824|25|3|226-231

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.25, Iss.3, 2008-01, pp. : 226-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Evaluation of Donepezil Treatment for Alzheimer’s Disease in Japan

By  

Dementia and Geriatric Cognitive Disorders, Vol. 13, Iss. 1, 2001-12 ,pp. : 33-39

Karger

Access to resources Recommend Favorite

Chronic Donepezil Treatment Is Associated with Slowed Cognitive Decline in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 12, Iss. 4, 2001-05 ,pp. : 295-300

Karger

Access to resources Recommend Favorite

An Observational Clinical Study of the Efficacy and Tolerability of Donepezil in the Treatment of Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 15, Iss. 4, 2003-03 ,pp. : 189-198

Karger

Access to resources Recommend Favorite

Donepezil for the Treatment of Mild to Moderate Alzheimer’s Disease in France: The Economic Implications

By  

Dementia and Geriatric Cognitive Disorders, Vol. 17, Iss. 1-2, 2003-12 ,pp. : 5-13

Karger

Access to resources Recommend Favorite

Two-Year Treatment of Alzheimer’s Disease with Eptastigmine

By  

Dementia and Geriatric Cognitive Disorders, Vol. 10, Iss. 2, 1999-02 ,pp. : 139-147

Karger

Access to resources Recommend Favorite